NEPHROS, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M | $2.3M | $1.9M | $1.7M | $1.7M | $1.8M | $2.2M | $2.9M |
| Cost of Revenue | $1.5M | $1.0M | $884.0K | $549.0K | $898.0K | $737.0K | $1.3M | $1.8M |
| Gross Profit | $2.3M | $1.3M | $1.1M | $1.2M | $842.0K | $1.1M | $868.0K | $1.1M |
| Gross Margin | 60.2% | 55.8% | 54.5% | 68.6% | 48.4% | 59.2% | 39.2% | 38.2% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.3M | $2.9M | $3.4M | $2.9M | $3.1M | $3.6M | $2.6M | $2.5M |
| Operating Income | $-2.2M | $-2.9M | $-3.4M | $-2.7M | $-3.3M | $-3.3M | $-2.3M | $-1.9M |
| Operating Margin | -58.4% | -123.7% | -176.0% | -152.7% | -190.6% | -184.4% | -104.3% | -64.3% |
| Interest Expense | $302.0K | $172.0K | $42.0K | $483.0K | $351.0K | $0 | $12.0K | $15.0K |
| Pretax Income | $-2.6M | $-3.0M | — | — | — | — | — | — |
| Income Tax Expense | $-1.8M | — | — | — | — | — | — | — |
| Net Income | $-809.0K | $-3.0M | $-3.1M | $-7.4M | $1.3M | $-6.6M | $-7.0M | $3.9M |
| Net Margin | -21.2% | -130.7% | -158.8% | -421.7% | 76.0% | -366.5% | -316.1% | 132.1% |
| EPS (Basic) | $-0.02 | $-0.06 | $-0.09 | $-0.31 | $0.08 | $-0.59 | $-0.81 | $1.86 |
| EPS (Diluted) | $-0.02 | $-0.06 | $-0.09 | $-0.31 | $-0.18 | $-0.59 | $-0.81 | $1.86 |
| Shares Outstanding (Basic) | 55.3M | 49.8M | 48.6M | 23.8M | 15.6M | 11.9M | 10.5M | 2.1M |
| Shares Outstanding (Diluted) | 55.3M | 49.8M | 48.6M | 23.8M | 20.8M | 11.9M | 10.5M | 2.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |